SEVERE WX : Red Flag Warning - Air Quality Alert View Alerts

CDC, FDA looking into risk of nerve complication after Johnson & Johnson COVID-19 vaccine

The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome.

Posted: Jul 12, 2021 4:43 PM
Updated: Jul 12, 2021 4:46 PM


The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome.

While the FDA said it had not established the vaccine could cause the syndrome, it noted an increase in reports of the sometimes paralyzing condition.

"Today, the FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination," it said in a statement sent to CNN.

"Reports of adverse events following use of the Janssen COVID-19 Vaccine under emergency use authorization suggest an increased risk of Guillain-Barré syndrome during the 42 days following vaccination," the updated label reads.

"Although the available evidence suggests an association between the Janssen vaccine and increased risk of GBS, it is insufficient to establish a causal relationship. No similar signal has been identified with the Moderna and Pfizer-BioNTech COVID-19 vaccines," the label adds.

The FDA said 100 preliminary reports of Guillain-Barré syndrome had been filed with the US government's Vaccine Adverse Reporting System, out of 12.8 million Janssen vaccines given.

"Guillain Barré syndrome (a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen COVID-19 Vaccine," the FDA says in the label update for patients and caregivers.

"In most of these people, symptoms began within 42 days following receipt of the Janssen COVID-19 Vaccine. The chance of having this occur is very low," it adds.

People should seek medical attention if they notice symptoms such as weakness or tingling in the arms and legs, especially if it spreads, after receiving a vaccine, the FDA said.

Other telltale symptoms include difficulty walking, speaking, chewing or swallowing; double vision; and bowel or bladder control problems.

The FDA said 95 of the 100 reports of GBS involved people who needed hospitalization, and one person died.

"Each year in the United States, an estimated 3,000 to 6,000 people develop GBS. Most people fully recover from the disorder," the agency added.

"GBS has also been observed at an increased rate associated with certain vaccines, including certain seasonal influenza vaccines and a vaccine to prevent shingles.

Johnson & Johnson confirmed it was talking to the US Centers for Disease Control and Prevention and FDA about the issue.

"We have been in discussions with the U.S. Food and Drug Administration and other regulators about rare cases of the neurological disorder, Guillain-BarreÌ syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine," the company said in a brief statement.

"The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree," it added.

Even if the vaccine does raise the risk of the syndrome, it's still better to get vaccinated against the coronavirus, the CDC stressed.

"GBS is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness or in the most severe cases paralysis. Each year in the United States, an estimated 3,000 to 6,000 people develop GBS; it is typically triggered by a respiratory or gastrointestinal infection. Most people fully recover from GBS," a CDC spokesperson told CNN.

"Reports of GBS after receipt of the J&J/Janssen COVID-19 Vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but do likely indicate a small possible risk of this side effect following this vaccine," the spokesperson added.

The spokesperson said the CDC's Advisory Committee on Immunization Practices would discuss the matter in an upcoming meeting.

"In the United States, nearly all COVID-19 hospitalizations and deaths are now occurring in unvaccinated people. The risk of severe adverse events after COVID-19 vaccination remains rare. Everyone age 12 years and older is recommended to receive a COVID-19 vaccine," the statement said.

The CDC and FDA briefly paused use of the Johnson & Johnson vaccine earlier this year because of a risk of a rare type of blood clotting complication but lifted the pause in April after determining the risk was low and the condition was treatable. The vaccine's label was updated to warn about the risk.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 224547

Reported Deaths: 2877
CountyCasesDeaths
Multnomah42425618
Washington28176259
Marion24842333
Clackamas20349243
Lane15401176
Jackson13240160
Deschutes1074187
Umatilla988394
Linn644882
Yamhill515882
Klamath498279
Douglas479594
Polk440457
Josephine438076
Malheur370967
Benton354822
Jefferson252842
Coos241040
Columbia213732
Union175924
Wasco160631
Lincoln159122
Crook144724
Hood River128934
Morrow125017
Clatsop123711
Baker116018
Curry86512
Tillamook7985
Grant5657
Lake4868
Harney46611
Wallowa2486
Gilliam881
Sherman872
Wheeler491
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 4003787

Reported Deaths: 64620
CountyCasesDeaths
Los Angeles131165624721
Riverside3112424667
San Bernardino3095025265
San Diego3011003805
Orange2856205146
Santa Clara1245862183
Sacramento1178311790
Kern1143421428
Fresno1057321746
Alameda980131290
Ventura845891046
Contra Costa78084836
San Joaquin776151461
Stanislaus666191097
Tulare50731854
San Mateo45255588
Monterey44651528
San Francisco41758565
Solano36525261
Santa Barbara36106469
Sonoma33414331
Merced33321485
Imperial29333746
Placer25624307
Kings23790251
San Luis Obispo22356267
Madera17220249
Santa Cruz16779207
Yolo15149215
Marin15039243
Butte13523205
Shasta13179242
El Dorado11312121
Napa1055282
Sutter10343127
Yuba712950
San Benito632664
Tehama592766
Lassen590526
Nevada568575
Humboldt535154
Mendocino485652
Tuolumne469173
Lake440866
Amador395348
Siskiyou259640
Glenn248127
Colusa238118
Calaveras235658
Del Norte174710
Inyo148238
Mono13395
Plumas7926
Modoc5767
Mariposa5377
Trinity4696
Sierra1370
Alpine910
Unassigned810
Medford
Partly Cloudy
67° wxIcon
Hi: 84° Lo: 59°
Feels Like: 67°
Brookings
Partly Cloudy
52° wxIcon
Hi: 76° Lo: 54°
Feels Like: 52°
Crater Lake
Clear
67° wxIcon
Hi: 64° Lo: 52°
Feels Like: 67°
Grants Pass
Partly Cloudy
67° wxIcon
Hi: 83° Lo: 62°
Feels Like: 67°
Klamath Falls
Partly Cloudy
50° wxIcon
Hi: 74° Lo: 53°
Feels Like: 50°
Smoky skies and spotty Thursday thunderstorms
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events